Hostname: page-component-745bb68f8f-b6zl4 Total loading time: 0 Render date: 2025-02-06T10:51:11.621Z Has data issue: false hasContentIssue false

Chronic non-granulomatous supraglottitis: a rare and difficult disease

Published online by Cambridge University Press:  29 May 2012

L G Ledgerwood
Affiliation:
Center for Voice and Swallowing, University of California, Sacramento, USA
P C Belafsky*
Affiliation:
Center for Voice and Swallowing, University of California, Sacramento, USA
*
Address for correspondence: Dr Peter C Belafsky, Center for Voice and Swallowing, University of California, Davis, 2521 Stockton Blvd, Suite 7200, Sacramento, CA 95817, USA Fax: +1 916 703 5011 E-mail: peterb@ucdvoice.org
Rights & Permissions [Opens in a new window]

Abstract

Objectives:

To examine chronic non-granulomatous supraglottitis, a rare disorder of uncertain aetiology with few reported cases in the literature.

Case reports:

We describe two cases of chronic non-granulomatous supraglottitis that led to persistent respiratory compromise. Patients underwent extensive investigation that failed to reveal a definitive diagnosis.

Conclusion:

In patients suffering from chronic inflammation of the supraglottic larynx without evidence of infection, neoplasm or granulomatous disease, many disorders must be ruled out in order to diagnose chronic non-granulomatous supraglottitis, which is a diagnosis of exclusion. We review the literature on this rare entity, discuss current management strategies, and suggest an algorithm for diagnostic investigation.

Type
Clinical Records
Copyright
Copyright © JLO (1984) Limited 2012

Introduction

Inflammatory disease of the supraglottic larynx is rare. The causes are myriad, and include: reflux,Reference Franco 1 environmental pollutants,Reference Marcotullio, Magliulo and Pezone 2 , Reference Kravos, Zupevc, Cizmarevic and Hocevar-Boltezar 3 granulomatous disorders,Reference Brass and White 5 syphilis,Reference Brass and White 5 , Reference Pace and Csonka 6 fungal infections,Reference Pochini Sobrinho, Della Negra, Queiroz, Ribeiro, Bittencourt and Klautau 7 , Reference Miller, Myer and Gray 8 viral infections,Reference Musharrafieh, Araj and Fuleihan 9 amyloidosis,Reference Eliachar and Lichtig 10 , Reference Hazenberg, Dikkers, Hawkins, Bijzet, Rowczenio and Gilbertson 11 Wegener's granulomatosis,Reference Talerman and Wright 12 chronic relapsing polychondritis,Reference Letko, Zafirakis, Baltatzis, Voudouri, Livir-Rallatos and Foster 13 sarcoidosis,Reference Haar, Chaudhry, Kaplan and Milley 14 systemic lupus erythematosusReference Scarpelli, McCoy and Scott 15 and hereditary angioedema.Reference Markovic, Inwards, Frigas and Phyliky 16 Reference Wong and Gadsden 18 Chronic non-granulomatous epiglottitis is an extremely rare entity with only a few reports in the literature.Reference Friedman, Toriumi and Strorigl 19 , Reference Schrottenbaum 20 We report two cases of chronic non-granulomatous supraglottitis that repeatedly led to respiratory compromise.

Case reports

Case one

The first patient was a 25-year-old man who presented with the chief complaints of mild dysphonia, globus, dyspnoea and dysphagia. One year prior to his presentation, he had suffered an upper respiratory tract infection, leading to respiratory arrest with emergent tracheostomy. His respiratory status had subsequently stabilised and he had been decannulated. At the time of presentation, the patient reported an unintended 14 kg weight loss over two months, with no other constitutional symptoms.

Video-laryngoscopy revealed a severely oedematous, omega-shaped epiglottis (Figure 1). The laryngeal oedema extended down both aryepiglottic folds and included the false vocal folds. The true vocal folds were mobile and without mass or lesion. Computed tomography of the neck demonstrated epiglottic thickening and airway constriction, with no evidence of significant lymphadenopathy (Figure 2).

Fig. 1 Video-laryngoscopic view of first patient's epiglottis, which was omega-shaped and severely oedematous.

Fig. 2 Axial computed tomography image of first patient, demonstrating the enlarged epiglottis and airway narrowing.

The patient underwent a direct laryngoscopy with biopsies. The biopsies of the epiglottis demonstrated inflammatory infiltrate without evidence of granulomas. Throat culture showed normal respiratory flora. The patient also underwent extensive laboratory investigation, including tests for complement (C) 3 and 4 levels, coccidioides titres, and cytoplasmic antineutrophilic cytoplasmic antibodies (ANCA) and perinuclear ANCA levels, all of which were negative.

Following the results of this investigation, the patient was offered definitive airway management by tracheostomy, but he instead elected for close observation and expectant management. There was a subsequent recurrence of the supraglottic oedema and the patient was admitted to the intensive care unit for antibiotic and steroid treatment, which resolved his symptoms. He endured a prolonged steroid taper and subsequently had an oedematous, but stable, airway. Repeated laryngoscopy continued to reveal evidence of chronic inflammation of the epiglottis and aryepiglottic folds.

Case two

The second patient was a 39-year-old woman who presented with a long history of ‘recurrent throat swelling’. Her symptoms had begun as an upper respiratory tract infection for which she had received treatment with antibiotics. She had improved with antibiotic therapy but the symptoms had subsequently recurred, and she had been seen by an otolaryngologist at another centre. At that time, flexible laryngoscopy had prompted immediate referral to the emergency department, and the patient had been intubated due to extensive epiglottic oedema. She had been extubated five days later following treatment with steroids and intravenous antibiotics.

Over the next 15 years, the patient had suffered seven further episodes of recurrent throat swelling, which had seemed to resolve with antibiotics. However, four months prior to the current presentation, she had suffered another episode of throat swelling; this episode had not responded adequately to antibiotics and the patient had been started on long-term prednisone, which had led to an improvement in symptoms. She had subsequently developed side-effects from the steroids, and the supraglottic oedema had persisted.

On video-laryngoscopy, the patient was noted to have oropharyngeal and hypopharyngeal oedema (Figure 3). The epiglottis was grossly swollen and the oedema extended to the aryepiglottic folds, and included the false vocal folds and postcricoid region.

Fig. 3 Video-laryngoscopic view of second patient's epiglottis, which was grossly swollen and the oedema extended to the aryepiglottic folds.

The patient underwent extensive laboratory investigation including cytoplasmic and perinuclear ANCA studies, coccidioides serology, and complement 3 and 4 levels. Her investigation was negative for any abnormalities, and she was taken to the operating theatre for direct laryngoscopy. Biopsies of the epiglottis and aryepiglottic folds revealed chronic inflammation, but no evidence of malignancy, granuloma, immunofluorescence or other abnormality (Figure 4).

Fig. 4 Photomicrograph of haematoxylin and eosin staining of the aryepiglottic fold of the second patient, demonstrating chronic inflammation and no evidence of granuloma formation. (×10)

The patient's symptoms improved with prolonged administration of steroids. Despite persistent supraglottic oedema, she had no further respiratory distress.

Discussion

A chronically enlarged epiglottis poses a diagnostic challenge. Patients typically present to their primary care physicians with chronic symptoms of dysphagia, dysphonia, a sore throat, and other non-specific symptoms that provide little assistance in securing a definitive diagnosis. Patients often undergo treatment with antibiotics or therapy for gastroesophageal reflux, which are prescribed by the primary care providers; they do not usually present to an otolaryngologist until symptoms have persisted for some time.

Once neoplasia has been ruled out by biopsy, many disorders must be included in the differential diagnosis.Reference Caldarelli, Friedberg and Harris 21 Laryngeal tuberculosis remains the most common granulomatous disease of the larynx.Reference Caldarelli, Friedberg and Harris 21 It is usually related to active pulmonary tuberculosis and may present with varying degrees of airway obstruction. Initially, there may be generalised supraglottic oedema that may ultimately lead to mucosal ulcerations. Diagnosis is obtained by isolating the acid-fast bacilli on culture and demonstrating the presence of tuberculin granulomas in the tissue. Anti-mycobacterial chemotherapy is the current treatment of choice for this disease.

Syphilitic infection of the larynx is usually noted during the secondary or tertiary phases of the disease, with the presence of diffuse erythematous papules within the larynx.Reference Pace and Csonka 6 , Reference Caldarelli, Friedberg and Harris 21 Diagnosis is based on the demonstration of positive venereal disease research laboratory or fluorescent treponemal antibody-absorption test results, and histology that shows vasculitis and lymphocytic infiltrate, with inconsistent isolation of the causative spirochaete. Treatment with antibiotics is effective in managing syphilis in the secondary phase of disease, but seldom in the tertiary phase of disease.

Infections involving candida species, indolent Haemophilus influenzae type B or actinomycosis can also lead to recurrent episodes of supraglottitis. These are usually successfully treated with antibiotic therapy once identified.Reference Parsons, Smith, Mair and Dlabal 22 Reference Wilson, Coutras and Tami 24 Viral infections should be ruled out as these may also play a role in recurrent epiglottitis.Reference Musharrafieh, Araj and Fuleihan 9

Patients with hereditary angioedema (C1-esterase deficiency) suffer from recurrent episodes of angioedema that can also involve the larynx and supraglottic structures.Reference Markovic, Inwards, Frigas and Phyliky 16 , Reference Wong and Gadsden 18 These patients will often present with facial swelling and some respiratory complaints, but symptoms rarely include stridor. Diagnosis is made based on a low level of complement 4. Reduced levels of C1-esterase and C1q confirm diagnosis. Treatment is usually directed at the underlying disease process, but if none is discovered, therapy with corticosteroids is usually curative.

Wegener's granulomatosis can also cause epiglottic enlargement with classic ulcerative, necrotic lesions, and oedematous and inflamed mucosa.Reference Talerman and Wright 12 The diagnosis is established by histopathologic findings of vasculitis, and scattered giant cells with poorly formed caseating granulomas.Reference Caldarelli, Friedberg and Harris 21 Wegener's granulomatosis is initially controlled by treatment with steroids, followed by cyclophosphamide or methotrexate for long-term therapy.

Two other cases of non-granulomatous chronic epiglottitis have been reported.Reference Friedman, Toriumi and Strorigl 19 , Reference Schrottenbaum 20 In one case, the patient additionally presented with perioral sores and cystic lesions on the aryepiglottic folds, consistent with a possible diagnosis of benign mucosal pemphigoid.Reference Friedman, Toriumi and Strorigl 19 , Reference Rosenfeld and Biller 25 The second reported case presented with similar symptoms to those of our patients, but there was no mention of the presence or absence of granulomatous changes in the article.Reference Schrottenbaum 20

While antibiotics and steroids have been the mainstay of therapy for oedema of the supraglottic airway, recent literature has examined hydroxychloroquine as a potential steroid-sparing therapy for recurrent airway oedema. Hydroxychloroquine is an antimalarial medication used extensively in the treatment of rheumatologic diseases such as rheumatoid arthritis and systemic lupus erythematosus.Reference Hirshoren, Eliashar and Weinberger 26 , Reference Kalia and Dutz 27 The medication interferes with antigen processing by raising the lysosomal pH and decreasing the function of various immune cells. It thus provides a potent immunomodulatory effect without steroid therapy. A recent report demonstrated the effectiveness of hydroxychloroquine as a steroid-sparing therapy in a case with subglottic stenosis.Reference Hirshoren, Eliashar and Weinberger 26 The patient had been steroid-dependent for over six months and was successfully converted to hydroxychloroquine, which was tapered off over a five-month period. Although this was a single case report, it represents a potential method of treating chronic non-granulomatous supraglottitis.

  • Chronic non-granulomatous supraglottitis is a diagnosis of exclusion

  • Patients present with chronic dysphonia, dyspnoea, globus and dysphagia

  • Diagnosis is made by laryngoscopy, imaging and histopathologic studies

  • Current management is aimed at airway maintenance with corticosteroids

  • Possible steroid-sparing therapies for chronic management are being explored

Given the disparate entities that can cause chronic supraglottitis, the investigation of patients with this condition is extensive. After full head and neck examination and flexible laryngoscopy, diagnostic investigation should proceed with basic evaluations, including complete blood count and biochemistry tests. Additional infectious markers should also be evaluated in accordance with the patient history (e.g. coccidioides, histoplasmosis and blastomycosis titres, depending on geographic locale). Ancillary studies such as cytoplasmic and perinuclear antineutrophilic cytoplasmic antibodies, complement 3 and 4 levels, erythrocyte sedimentation rate, C-reactive protein, fluorescent treponemal antibody-absorption, venereal disease research laboratory tests, and purified protein derivative should be carried out as symptoms dictate.

If this preliminary investigation remains inconclusive, evaluation by direct laryngoscopy and biopsy should be performed to rule out neoplasm and establish the presence of granulomas or chondrocyte degeneration. Direct immunofluorescence should be performed to rule out pemphigoid, and positive birefringence under polarised light should be utilised to rule out amyloidosis. If, despite these efforts, the diagnosis is not elucidated, an empirical trial of oral steroids is recommended, with close monitoring to ensure improvement. It is also reasonable to perform ambulatory pH testing to rule out any contribution from laryngopharyngeal reflux. Patients who fail steroid therapy or cannot tolerate the side-effects may also warrant referral to a rheumatologist to discuss hydroxychloroquine therapy as an alternative. Management of the airway is dictated by the severity of the patient's symptoms, wherein a tracheostomy is the gold standard in airway management for recurrent supraglottic oedema.

Conclusion

Chronic non-granulomatous supraglottitis remains a diagnosis of exclusion in patients with chronic inflammation of the supraglottis. Patients may present with chronic dysphonia, dyspnoea, globus and dysphagia. The condition can be exacerbated by infection, leading to respiratory compromise. Diagnosis is made by flexible laryngoscopy, radiological imaging demonstrating epiglottic oedema, and histology suggestive of chronic inflammatory changes in the absence of granulomas, infection, or other diagnosis. Management is primarily focused on airway maintenance with corticosteroids, but possible steroid-sparing therapies for chronic management are being explored.

Acknowledgement

The authors would like to thank Dr Heidi Jess for her assistance in obtaining the photomicrograph for this manuscript.

Footnotes

Presented as a poster at the American Laryngological Association as part of the Combined Otolaryngological Spring Meetings, 27–28 April 2011, Chicago, Illinois, USA

References

1 Franco, RA Jr. Laryngopharyngeal reflux. Allergy Asthma Proc 2006;27:21–5Google ScholarPubMed
2 Marcotullio, D, Magliulo, G, Pezone, T. Reinke's edema and risk factors: clinical and histopathologic aspects. Am J Otolaryngol 2002;23:81–4CrossRefGoogle ScholarPubMed
3 Kravos, A, Zupevc, A, Cizmarevic, B, Hocevar-Boltezar, I. The role of allergy in the etiology of Reinke's edema on vocal folds. Wien Klin Wochenschr 2010;122(suppl 2):44–8CrossRefGoogle ScholarPubMed
4 Parab, SR, Khan, MM, Ghaisas, VS. Simultaneous involvement of larynx and middle ear in pulmonary tuberculosis. Laryngoscope 2010;120:1892–4CrossRefGoogle ScholarPubMed
5 Brass, LS, White, JA. Granulomatous disease of the larynx. J La State Med Soc 1991;143:1114 Google ScholarPubMed
6 Pace, JL, Csonka, GW. Late endemic syphilis: case report of bejel with gummatous laryngitis. Genitourin Med 1988;64:202–4Google ScholarPubMed
7 Pochini Sobrinho, F, Della Negra, M, Queiroz, W, Ribeiro, UJ, Bittencourt, S, Klautau, GB. Histoplasmosis of the larynx. Braz J Otorhinolaryngol 2007;73:857–61CrossRefGoogle ScholarPubMed
8 Miller, R, Myer, CM 3rd, Gray, S. Otolaryngologic manifestations of chronic granulomatous disease. Am J Otolaryngol 1988;9:7982 CrossRefGoogle ScholarPubMed
9 Musharrafieh, UM, Araj, GF, Fuleihan, NS. Viral supraglottitis in an adult: a case presentation and literature update. J Infect 1999;39:157–60CrossRefGoogle Scholar
10 Eliachar, I, Lichtig, C. Local amyloid deposits of the larynx. Electron microscopic studies of three cases. Arch Otolaryngol 1970;92:163–6CrossRefGoogle ScholarPubMed
11 Hazenberg, AJ, Dikkers, FG, Hawkins, PN, Bijzet, J, Rowczenio, D, Gilbertson, J et al. Laryngeal presentation of systemic apolipoprotein A-I-derived amyloidosis. Laryngoscope 2009;119:608–15CrossRefGoogle ScholarPubMed
12 Talerman, A, Wright, D. Laryngeal obstruction due to Wegener's granulomatosis. Arch Otolaryngol 1972;96:376–9CrossRefGoogle ScholarPubMed
13 Letko, E, Zafirakis, P, Baltatzis, S, Voudouri, A, Livir-Rallatos, C, Foster, CS. Relapsing polychondritis: a clinical review. Semin Arthritis Rheum 2002;31:384–95CrossRefGoogle ScholarPubMed
14 Haar, JG, Chaudhry, AP, Kaplan, HM, Milley, PS. Granulomatous laryngitis of unknown etiology. Laryngoscope 1980;90:1225–9CrossRefGoogle ScholarPubMed
15 Scarpelli, DG, McCoy, FW, Scott, JK. Acute lupus erythematosus with laryngeal involvement. N Engl J Med 1959;261:691–4CrossRefGoogle ScholarPubMed
16 Markovic, SN, Inwards, DJ, Frigas, EA, Phyliky, RP. Acquired C1 esterase inhibitor deficiency. Ann Intern Med 2000;132:144–50CrossRefGoogle ScholarPubMed
17 Small, P, Frenkiel, S. Hereditary angioneurotic edema first observed as an epiglottiditis. Arch Otolaryngol 1983;109:195–6CrossRefGoogle ScholarPubMed
18 Wong, DT, Gadsden, JC. Acute upper airway angioedema secondary to acquired C1 esterase inhibitor deficiency: a case report. Can J Anaesth 2003;50:900–3CrossRefGoogle ScholarPubMed
19 Friedman, M, Toriumi, DM, Strorigl, T. Chronic nongranulomatous epiglottitis. Ear Nose Throat J 1988;67:524–7Google ScholarPubMed
20 Schrottenbaum, M. Unusual chronic epiglottis inflammation [in German]. Zentralbl Allg Pathol 1963;104:255–7Google ScholarPubMed
21 Caldarelli, DD, Friedberg, SA, Harris, AA. Medical and surgical aspects of the granulomatous diseases of the larynx. Otolaryngol Clin North Am 1979;12:767–81CrossRefGoogle ScholarPubMed
22 Parsons, DS, Smith, RB, Mair, EA, Dlabal, LJ. Unique case presentations of acute epiglottic swelling and a protocol for acute airway compromise. Laryngoscope 1996;106:1287–91CrossRefGoogle Scholar
23 Sharma, N, Berman, DM, Scott, GB, Josephson, G. Candida epiglottitis in an adolescent with acquired immunodeficiency syndrome. Pediatr Infect Dis J 2005;24:91–2CrossRefGoogle Scholar
24 Wilson, JF, Coutras, S, Tami, TA. Recurrent adult acute epiglottitis: the role of lingual tonsillectomy. Ann Otol Rhinol Laryngol 1989;98:602–4CrossRefGoogle ScholarPubMed
25 Rosenfeld, RM, Biller, HF. Chronic nongranulomatous epiglottitis. Ear Nose Throat J 1989;68:265 Google ScholarPubMed
26 Hirshoren, N, Eliashar, R, Weinberger, JM. Hydroxychloroquine for subglottic stenosis: a novel therapy in the battle for air. Laryngoscope 2010;120:743–4CrossRefGoogle ScholarPubMed
27 Kalia, S, Dutz, JP. New concepts in antimalarial use and mode of action in dermatology. Dermatol Ther 2007;20:160–74CrossRefGoogle ScholarPubMed
Figure 0

Fig. 1 Video-laryngoscopic view of first patient's epiglottis, which was omega-shaped and severely oedematous.

Figure 1

Fig. 2 Axial computed tomography image of first patient, demonstrating the enlarged epiglottis and airway narrowing.

Figure 2

Fig. 3 Video-laryngoscopic view of second patient's epiglottis, which was grossly swollen and the oedema extended to the aryepiglottic folds.

Figure 3

Fig. 4 Photomicrograph of haematoxylin and eosin staining of the aryepiglottic fold of the second patient, demonstrating chronic inflammation and no evidence of granuloma formation. (×10)